Clinical Trial Update: A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide with melphalan and dexamethasone in AL amyloidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Melphalan (Melphalan)

Snippet

Sponsor: Heidelberg University | Conditions: Primary Amyloidosis | Phase 2 | Status: COMPLETED